News
Novavax's growth relies on Sanofi royalties and COVID/flu vaccines, lacking innovation and clear catalysts. Click here to ...
Each week on LinkedIn, business leaders announce moves to and from companies that play a role in our daily lives. See notable ...
A Wall Street maxim states, “Twenty percent of investors who want to make money are in stocks, while the other 80 percent who ...
10h
Zacks Investment Research on MSNWill Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report?Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report ...
In the latest twist in the ocean of Zantac-related litigation playing out across state courts, drugmakers have notched a key ...
Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...
Pfizer faces adjusted financial forecasts as analysts lower earnings expectations for FY2025, signaling cautious optimism.
RFK Jr. cancels U.S. Preventive Services Task Force meeting; the Department of Health and Human Services backtracked on its claim that it would release ethics forms for new members of the Advisory ...
Last month, during Cannes Lions, Netflix announced that its ad inventory will be available to buy programmatically via Yahoo ...
22hOpinion
MedPage Today on MSNFDA Didn't Really Give 'Full Approval' to Moderna's Pediatric COVID VaccineHow did we get here? Until now, vaccines for all children under age 12 had been available under emergency use authorization ...
US regulators approved Moderna Inc.’s COVID-19 vaccine for children, but for a narrower group than before, continuing Robert ...
The Food and Drug Administration (FDA) granted full approval on Thursday to Moderna’s COVID-19 vaccine for children, making it the first COVID shot for kids aged 6 months to 11 years old that is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results